Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award Director acquired 13,700 shares (grant or award)
  2. 4 Grant or award Director acquired 13,700 shares (grant or award)
  3. 4 Open-market sale CCO sold 6,426 shares at $11.58 ($74,413)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale SVP, Chief Operating Officer sold 6,972 shares at $8.70 ($60,656)
  7. 4 Open-market sale SVP, Chief Legal Officer sold 7,050 shares at $8.70 ($61,335)
  8. 4 Open-market sale SVP, CFO & Treasurer sold 6,976 shares at $8.70 ($60,691)
  9. 4 Open-market sale SVP, Chief Development Officer sold 3,454 shares at $8.70 ($30,050)
  10. 4 Grant or award CEO and President acquired 237,400 shares (grant or award)
  11. 4 Grant or award SVP, Chief Medical Officer acquired 62,000 shares (grant or award)
  12. 4 Grant or award CCO acquired 55,000 shares (grant or award)
  13. 5 Insider Annual Insider Trading Report
  14. 4 Open-market buy Director bought 5,800 shares at $3.43 ($19,894)
  15. 4 Open-market buy Director bought 15,000 shares at $3.52 ($52,800)
  16. 4 Open-market buy SVP, Chief Medical Officer bought 27,000 shares at $3.58 ($96,660)
  17. 4 Open-market buy CEO and President bought 50,000 shares at $3.44 ($172,000)
  18. 4 Open-market buy Director bought 50,000 shares at $3.41 ($170,500)
  19. 4 Grant or award SVP, Chief Medical Officer acquired 10,000 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 9 of 19 · 378 filings